NCT07004933 - Rapid Antiretroviral Treatment Initiation With BIC/FTC/TAF in HIV-infected People Who Inject Drugs (PWID) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 22, 2021

Primary Completion Date

December 9, 2024

Study Completion Date

December 9, 2024

Conditions

HIV Positive People Who Inject Drugs

Interventions

DRUG

bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF)

Rapid antiretroviral treatment initiation with BIC/FTC/TAF

Trial Locations (3)

"General Hospital of Athens EVAGGELISMOS", Athens

"General Hospital of Athens LAIKO", Athens

"University General Hospital ATTIKON", Athens